LONDON – Mologic Ltd. is poised to plug a hole in the dyke of rapid diagnostic tests (RDTs) for malaria, delivering a yes/no test that will indicate if it is safe to treat a patient with primaquine, the 8-aminoquinoline drug that is the only means of killing the Plasmodium vivax parasite when it is lying dormant in the liver.